Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza
Top Cited Papers
- 16 June 2001
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 357 (9272), 1937-1943
- https://doi.org/10.1016/s0140-6736(00)05066-2
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Antibody Response in Individuals Infected with Avian Influenza A (H5N1) Viruses and Detection of Anti‐H5 Antibody among Household and Social ContactsThe Journal of Infectious Diseases, 1999
- Characterization of Avian H5N1 Influenza Viruses from Poultry in Hong KongVirology, 1998
- Human influenza A H5N1 virus related to a highly pathogenic avian influenza virusThe Lancet, 1998
- Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virusThe Lancet, 1998
- Development of an Adjuvant to Enhance the Immune Response to Influenza Vaccine in the ElderlyBiologicals, 1997
- Molecular analysis of an outbreak of influenza in the United KingdomEuropean Journal of Epidemiology, 1997
- Avian influenza virus isolated from a woman with conjunctivitisThe Lancet, 1996
- Replication of avian influenza viruses in humansArchiv für die gesamte Virusforschung, 1991
- Quantitation and analysis of the specificity of post-immunization antibodies to influenza B viruses using single radial haemolysisEpidemiology and Infection, 1982
- Conjunctivitis in Human Beings Caused by Influenza A Virus of SealsThe New England Journal of Medicine, 1981